Меню
Идёт набор NCT06873113

BFRT for Subacromial Pain

Без фазы С лечением Shoulder Pain

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Active BFRT, Sham BFRT, Strengthening Exercises with BFRT, Skilled Physical Therapy Care.
Кому может быть актуально
Состояния в реестре: Shoulder Pain. Базовые параметры: 18 лет — 50 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
США
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Blood Flow Restriction Training for Subacromial Pain: A Pilot Randomized Controlled Trial

Обзор

The goal of this pilot clinical trial is to learn if blood flow restriction training is safe and feasible in patients with subacromial pain. The main questions the investigators aim to answer are: * What problems do participants with shoulder pain encounter when training with blood flow restriction? * Is it feasible to apply blood flow restriction training as part of a physical therapy intervention? * What are some preliminary effects of blood flow restriction training on the recovery of shoulder function and strength? The investigators will compare active blood flow restriction training to sham (an inactive procedure designed to mimic the active training as closely as possible). Participants will: * Visit the clinic for physical therapy visits and exercise with blood flow restriction training for up to 8 weeks * Visit the clinic for tests before starting the treatment, during the treatment (4 weeks), and after the end of the treatment (8 and 26 weeks).

Вмешательства

  • Устройство Active BFRT
    The BFR device is applied unilaterally on participants involved upper extremity. The BFR device maintains 50% of participants limb occlusion pressure for the duration of each strengthening exercise.
  • Устройство Sham BFRT
    The BFR device is applied unilaterally on participants involved upper extremity. The BFR device maintains a pressure of 20mmHg for the duration of each strengthening exercise.
  • Поведенческое Strengthening Exercises with BFRT
    Participants perform 4 strengthening exercises while using the BFR device: seated scapular plane elevation, prone horizontal abduction, side-lying external rotation, and prone scapular plane elevation. Each exercise is performed unilaterally. Participants perform 1 set of 30 repetitions followed by 3 sets of 15 repetitions (4 total sets, 75 total repetitions). Participants are given 30 seconds rest between sets and 2 minutes of rest between strengthening exercises. Selected resistance for each s
  • Поведенческое Skilled Physical Therapy Care
    Participants perform non-strengthening interventions as part of skilled physical therapy care. Non-strengthening interventions include an upper arm ergometer for warm-up, active assisted range of motion of the shoulder, shoulder stretching, shoulder joint mobilizations, and cryotherapy. Non-strengthening interventions are prescribed at the discretion of the treating physical therapist. Participants are enrolled in physical therapy for a minimum of 4 weeks. After 4 weeks, the treating physical th

Первичные конечные точки

  • Recruitment [Срок оценки: Monthly report from beginning to completion of recruitment (anticipated 2 years)]
  • Intervention feasibility [Срок оценки: Weekly record from enrollment to the end of treatment at 8 weeks.]
Вторичные конечные точки (12)
  • Retention [Срок оценки: Weekly record from enrollment to 26 weeks (end of the trial).]
  • Intervention safety [Срок оценки: Weekly record from enrollment to 26 weeks (end of the trial).]
  • Participants masking feasibility [Срок оценки: At 8 weeks]
  • Patient acceptability [Срок оценки: At 8 weeks]
  • Range of motion [Срок оценки: From enrollment to 4 weeks, 8 weeks and 6 months]
  • Strength [Срок оценки: From enrollment to 4 weeks, 8 weeks and 6 months]
  • Timed Functional Arm and Shoulder Test (TFAST) [Срок оценки: From enrollment to 4 weeks, 8 weeks and 6 months]
  • Supraspinatus and infraspinatus muscle cross-sectional area [Срок оценки: From enrollment to 4 weeks, 8 weeks and 6 months]
  • Supraspinatus tendon morphology [Срок оценки: From enrollment to 4 weeks, 8 weeks and 6 months]
  • Supraspinatus tendon elastography [Срок оценки: From enrollment to 4 weeks, 8 weeks and 6 months]
  • Pennsylvania Shoulder Score (PENN) [Срок оценки: From enrollment to 4 weeks, 8 weeks and 6 months]
  • Global rating of change (GROC) [Срок оценки: At 4 weeks, 8 weeks and 6 months]

Критерии участия

Критерии включения

  • Between 18 and 50 years of age
  • Unilateral pain in the anterolateral shoulder
  • Self-reported shoulder function of ≤7 (10, full function)
  • At least 90° of active shoulder elevation
  • 3 out of 5 positive tests to define subacromial pain.

Exclusion Criteria (general):

  • history of shoulder fracture, frozen shoulder, or shoulder surgery
  • primary complaint of shoulder instability/dislocation
  • history of cardiovascular, neurologic, and pulmonary conditions that would impair the subject's ability to participate in physical therapy
  • active treatment for cancer
  • uncontrolled diabetes
  • uncontrolled high blood pressure
  • corticosteroid injection at the shoulder within 6 weeks
  • imaging evidence of rotator cuff tears
  • pregnancy

Exclusion criteria (Blood flow restriction training specific)

  • contraindications to BFRT (sickle cell anemia, deep vein thrombosis, peripheral circulatory diseases)
  • taking anticoagulant or antiplatelet drugs

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Тройное слепое
Основная цель
Другое

Центры проведения

США · 1 центр
  • University of Florida — Gainesville

Идентификаторы

NCT: NCT06873113 · IRB202302184 · R21AR082588-01A1

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗